PTGS2 and ovarian carcinoma: NSAIDs and selective COX-2 inhibitors delay the development of endometrial cancer, ovarian cancer, and cervical cancer (Daikoku et al., 2005; Hasegawa et al., 2005; Kim et al., 2013).